Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Ramelteon in Chronic Insomnia
NCT00671086Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2003
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ramelteon in Insomnia (2 arms), sponsored by Takeda. Primary endpoints: Adverse Events at Month 12, Change from Baseline in Vital Signs at Month 12 and 6 more. Started Feb 2003; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00671086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671086.